Skip to main content
SpringerLink
Log in

Bleeding Complications and Reduction of Coagulation Factors

  • Chapter
  • First Online:
The Concise Manual of Apheresis Therapy

  • 1237 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Mokrzycki MH et al (1994) Therapeutic plasma exchange: ­complications and management. Am J Kidney Dis 23(6):817–827

    PubMed  CAS  Google Scholar 

  2. Kaplan AA (2008) Therapeutic plasma exchange: core curriculum 2008. Am J Kidney Dis 52(6):1180–1196

    Article  PubMed  Google Scholar 

  3. Hanafusa N (2011) Theoretical basis of pathogenic substance removal during plasmapheresis. Ther Apher Dial 15(5):421–430

    Article  PubMed  CAS  Google Scholar 

  4. Hanafusa N et al (2007) Double filtration plasmapheresis can decrease factor XIII activity. Ther Apher Dial 11(3):165–170

    Article  PubMed  CAS  Google Scholar 

  5. Hanafusa N et al (2010) Virus removal and eradication by modified double filtration plasmapheresis decreases factor XIII levels. Ther Apher Dial 14(3):287–291

    Article  PubMed  Google Scholar 

  6. Gerlach R et al (2000) Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures. Surg Neurol 54(3):260–264 (discussion 264–265)

    Article  PubMed  CAS  Google Scholar 

  7. Hanafusa N et al (2013) The effect of different apheresis modalities on coagulation factor XIII level during antibody removal in ABO-blood type incompatible living related renal transplantation. Transfus Apher Sci (in press)

    Google Scholar 

  8. Hanafusa N et al (2010) A patient whose factor XIII level was decreased by double filtrate plasmapheresis and successfully recovered by infusion of factor XIII concentrate. Ther Apher Dial 14(4):432–433

    Article  PubMed  Google Scholar 

  9. Seishima M et al (2009) Decreased factor XIII activity in a patient with subcutaneous bleeding after double filtration plasmapheresis. Ther Apher Dial 13(3):229–231

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hemodialysis & Apheresis, University Hospital, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan

    Norio Hanafusa

Authors
  1. Norio Hanafusa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Norio Hanafusa .

Editor information

Editors and Affiliations

  1. Department of Hemodialysis & Apheresis, University Hospital The University of Tokyo, Bunkyo-ku, Tokyo, Japan

    Eisei Noiri

  2. Department of Hemodialysis & Apheresis, University Hospital The University of Tokyo, Bunkyo-ku,, Tokyo, Japan

    Norio Hanafusa

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Japan

About this chapter

Cite this chapter

Hanafusa, N. (2014). Bleeding Complications and Reduction of Coagulation Factors. In: Noiri, E., Hanafusa, N. (eds) The Concise Manual of Apheresis Therapy. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54412-8_18

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-54412-8_18

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-54411-1

  • Online ISBN: 978-4-431-54412-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation